Association of serum fetuin‐A with carotid arterial stiffness
- 18 December 2006
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 66 (2) , 246-250
Abstract
Summary: Objective Fetuin‐A is a circulating glycoprotein which is well characterized as an inhibitor of ectopic calcification. Vascular calcification commonly found in chronic kidney disease (CKD) patients is a predictor of cardiovascular death. Recently, several groups have demonstrated that low fetuin‐A levels are associated with mortality in uraemic patients, possibly through regulation of vascular calcification. However, the physiological significance of fetuin‐A in atherosclerosis remains unknown, except in specific conditions, such as vascular calcification in CKD patients. The objective of this study was to investigate the association between serum fetuin‐A levels and arterial stiffness, a functional property of atherosclerosis, in healthy subjects.Patients and measurements The study subjects comprised 141 healthy subjects. We measured serum fetuin‐A levels and stiffness parameter β for the common carotid artery, which was assessed by ultrasound using a phase‐locked echo‐tracking system.Results Simple regression analyses indicated that serum fetuin‐A levels were significantly correlated with stiffness parameter β (r = 0·200, P = 0·018). Multiple regression analyses showed that, besides age, fetuin‐A (β = 0·166, P = 0·033) independently contribute to the stiffness parameter β (R2 = 0·310, P < 0·0001).Conclusions Serum fetuin‐A level is associated with carotid arterial stiffness, independent of known atherogenic factors in healthy subjects.Keywords
This publication has 30 references indexed in Scilit:
- Association of Serum Fetuin-A With Insulin Resistance in Type 2 Diabetic and Nondiabetic SubjectsDiabetes Care, 2006
- The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcificationJournal of Clinical Investigation, 2003
- Improved Insulin Sensitivity and Resistance to Weight Gain in Mice Null for the Ahsg GeneDiabetes, 2002
- α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and RemodelingJournal of Biological Chemistry, 2002
- α2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptorMolecular and Cellular Endocrinology, 2000
- Regulation of Osteogenesis by FetuinJournal of Biological Chemistry, 1999
- The Serum Protein α2-HS Glycoprotein/Fetuin Inhibits Apatite Formation in Vitro and in Mineralizing Calvaria CellsJournal of Biological Chemistry, 1996
- Fetuin/α2-HS Glycoprotein Is a Transforming Growth Factor-β Type II Receptor Mimic and Cytokine AntagonistJournal of Biological Chemistry, 1996
- Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activityCell, 1989
- Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant.Journal of Clinical Investigation, 1979